These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33187719)

  • 1. Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment.
    Baud FJ; Houzé P; Carli P; Lamhaut L
    Therapie; 2021; 76(5):415-424. PubMed ID: 33187719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diafiltration flowrate is a determinant of the extent of adsorption of amikacin in renal replacement therapy using the ST150
    Baud FJ; Houzé P; Raphalen JH; Winchenne A; Philippe P; Carli P; Lamhaut L
    Int J Artif Organs; 2020 Dec; 43(12):758-766. PubMed ID: 32356511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of fluconazole during continuous renal replacement therapy. An in vitro assessment.
    Baud FJ; Jullien V; Abarou T; Pilmis B; Raphalen JH; Houzé P; Carli P; Lamhaut L
    Int J Artif Organs; 2021 Jul; 44(7):453-464. PubMed ID: 33222594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of three doses of gentamicin over three consecutive days using a polyacrylonitrile-derived filter: An in vitro assessment.
    Baud FJ; Seif V; Houzé P; Raphalen JH; Pilmis B; Carli P; Lamhaut L
    Int J Artif Organs; 2021 Oct; 44(10):641-650. PubMed ID: 34348515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of cefotaxime using polysulfone and polyacrylonitrile-derived filters: An
    Le Ven J; Pellan C; Maulet V; Le Monnier A; Baud FJ
    Int J Artif Organs; 2023 Feb; 46(2):113-119. PubMed ID: 36583520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin Sequestration in ST Filters: An In Vitro Study.
    Baud FJ; Houzé P; Raphalen JH; Philippe P; Lamhaut L
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    Krueger CK; Bruno JJ; Tverdek FP; Hernandez M; Abudayyeh A
    Ann Pharmacother; 2023 Jun; 57(6):629-636. PubMed ID: 36062536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous renal replacement therapy in the treatment of severe hyperkalemia: An in vitro study.
    Houzé P; Baud FJ; Raphalen JH; Winchenne A; Moreira S; Gault P; Carli P; Lamhaut L
    Int J Artif Organs; 2020 Feb; 43(2):87-93. PubMed ID: 31509049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are we correctly treating invasive candidiasis under continuous renal replacement therapy with echinocandins? Preliminary in vitro assessment.
    Baud FJ; Jullien V; Secrétan PH; Houzé P; Lamhaut L
    Anaesth Crit Care Pain Med; 2021 Feb; 40(1):100640. PubMed ID: 32251833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans.
    Contrepois A; Brion N; Garaud JJ; Faurisson F; Delatour F; Levy JC; Deybach JC; Carbon C
    Antimicrob Agents Chemother; 1985 Apr; 27(4):520-4. PubMed ID: 4004192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspofungin sequestration in a polyacrylonitrile-derived filter: Increasing the dose does not mitigate sequestration.
    Baud FJ; Jullien V; Desnos-Ollivier M; Lamhaut L; Lortholary O
    Int J Antimicrob Agents; 2023 Dec; 62(6):107007. PubMed ID: 37839719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Malassezia pachydermatis to aminoglycosides.
    Silva FA; Conde-Felipe M; Rosario I; Ferrer O; Real F; Déniz S; Acosta F; Padilla D; Acosta-Hernández B
    Mycoses; 2017 Dec; 60(12):796-799. PubMed ID: 28925032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of gentamicin and amikacin in extracorporeal membrane oxygenation using a heparin-coated filter: An in vitro assessment.
    Baud FJ; Wasram Jetha-Jamal T; Vicca S; Raphalen JH; Lamhaut L
    Int J Artif Organs; 2022 Jun; 45(6):588-592. PubMed ID: 35531752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
    Potel G; Caillon J; Fantin B; Raza J; Le Gallou F; Lepage JY; Le Conte P; Bugnon D; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1991 Jan; 35(1):111-6. PubMed ID: 2014965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.
    Young DC; Zobell JT; Stockmann C; Waters CD; Ampofo K; Sherwin CM; Spigarelli MG
    Pediatr Pulmonol; 2013 Nov; 48(11):1047-61. PubMed ID: 24000183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycosides in the Intensive Care Unit: What Is New in Population PK Modeling?
    Duong A; Simard C; Wang YL; Williamson D; Marsot A
    Antibiotics (Basel); 2021 Apr; 10(5):. PubMed ID: 33946905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
    Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.